3Jenkins RB, Blair H, Ballman KV, et al. At (1 ; 19) (q10;p10) Mediates the combined deletions of 1 p and 19 q and predicts a better prognosis of patients with oligodendroglioma. J Cancer Res, 2006,66 ( 20 ) : 9852 -9861. 被引量：1
4Brandes AA, Tosonl A, Cavallo G, et al. Correlations between O6-methyguanine DNA methyhransferase promoter methylation status, 1 p and 19 q deletions, and response to temozolomide in anaplastic and rcurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol ,2006,24 (29) :4746-475. 被引量：1
5Idbaih A, Omuro A, Ducray F, et al. Molecular genetic markers as predictors of response to chemotherapy in gliomas. Curr Opin Oncol. 2007, 19(6) :606-611. 被引量：1
6Balana C, Ramirez JL, Taron M, et al. O6-methylguanine- DNA methyltansese methylation in serum and tumor DNA predicts response to 1 , 3 - bis ( 2 - chloroethyl ) - 1 - nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. J Clin Cancer Res, 2003,9(4) : 1461-1468. 被引量：1
7Groves MD, Puduvalli VK, Chang SM, et al. A North American brain tumor consortium ( NABTC 99-04 ) phase Ⅱ trial of temozolomide plus thalidomide for recurrent glioblastoma muhiforme. J Neurooncol. 2007,81 ( 3 ) : 271-277. 被引量：1
8Hegi ME, Murat A, Lambiv WL, el al. Brain tumors : molecular biology and targeted therapies. J Ann Oncol 2006, 17 ( Suppl 10) :x191-197. 被引量：1
9Esteller M, Hamilton SR, Burger PC, et al. Inactivation Of the DNA repair gene O6-methylguanine-DNA methyltansfese by promoter hypermethylation is a common event in primary human neoplasia. J Cancer Res 1999,59 (4) :793 -797. 被引量：1
10Balana C, Carrato C, Ramirez J, et al. Concordance and clinical value of MGMT promoter methylation pattern in tissue with paired serum and MGMT promoter methylation pattern in a series of glioblastoma ( GB ) patients. JClin Oncol, 2008 , 26 Suppl : 98. 被引量：1
